What they were paid
Dianthus Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $30,357 | — | $351,952 | — | $382,309 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Dianthus Therapeutics, Inc. DEF 14A filed April 9, 2026, accession 0001690585-26-000012, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Dianthus Therapeutics pays directors a $40,000 cash retainer and $12,500 in Options.
Committees
FY2025 · as the proxy prints themNominating/Governance · Science and Technology
The rest of the Dianthus Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Alison F. Lawton | Independent Director | $259,787 |
| Anne McGeorge | Independent Director | $232,382 |
| Jonathan Violin, Ph.D | Independent Director | $217,476 |
| Marino Garcia | Director | $0 |
| Paula Soteropoulos | Independent Director | $231,787 |
| Steven Romano, M.D | Independent Director | $225,647 |
| Sujay Kango | Independent Director | $418,860 |
The full Dianthus Therapeutics compensation record
free company briefThis page is one director within Dianthus Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat